Vlad Ratziu Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

4/2024	Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH.
12/2023	FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis of a randomised, double-blind, placebo-controlled, phase 2b trial.
12/2020	Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis.
1/2020	Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
1/2020	Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study.
1/2017	Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
3/2016	Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design.
9/2014	Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".
7/2011	Prognostic value of liver fibrosis biomarkers: a meta-analysis.
1/2009	The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vlad Ratziu Research Topics

Disease

114	Fibrosis (Cirrhosis) 04/2024 - 09/2002
90	Non-alcoholic Fatty Liver Disease 04/2024 - 12/2005
53	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 09/2002
33	Liver Diseases (Liver Disease) 01/2024 - 12/2002
28	Alcoholic Fatty Liver 12/2023 - 09/2007
25	Fatty Liver 12/2023 - 12/2005
25	Chronic Hepatitis C 11/2018 - 09/2002
16	Inflammation (Inflammations) 03/2022 - 02/2010
12	Insulin Resistance 11/2021 - 02/2004
11	Type 2 Diabetes Mellitus (MODY) 05/2023 - 07/2008
8	Infections 05/2015 - 12/2003
8	Hepatitis C 03/2009 - 06/2002
7	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 05/2015
7	Disease Progression 12/2023 - 09/2011
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 12/2003
7	Hepatitis 01/2020 - 01/2006
7	Chronic Hepatitis B 11/2014 - 08/2003
5	Obesity 03/2022 - 08/2011
5	Alcoholic Liver Diseases (Alcoholic Liver Disease) 11/2018 - 02/2005
4	Weight Loss (Weight Reduction) 05/2023 - 08/2011
4	Pruritus (Itching) 01/2023 - 12/2019
4	Body Weight (Weight, Body) 01/2023 - 01/2019
3	Weight Gain 10/2021 - 07/2008
3	Liver Neoplasms (Liver Cancer) 08/2021 - 12/2003
3	Dyslipidemias (Dyslipidemia) 12/2020 - 05/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 02/2006
2	Nausea 01/2024 - 10/2021
2	Diarrhea 01/2024 - 10/2021
2	Gilbert Disease 10/2023 - 01/2019
2	Lipodystrophy 01/2023 - 01/2019
2	COVID-19 03/2022 - 01/2020
2	Neoplasms (Cancer) 01/2021 - 03/2003
2	Abdominal Obesity 01/2020 - 03/2012
2	Wolman Disease (Wolman's Disease) 01/2020 - 01/2018
2	Cryptogenic Cirrhosis 12/2018 - 12/2016
2	Morbid Obesity 01/2017 - 01/2012
2	Chemical and Drug Induced Liver Injury 01/2017 - 02/2014
2	Hypertension (High Blood Pressure) 01/2016 - 05/2015
2	Overweight 05/2015 - 12/2003

Drug/Important Bio-Agent (IBA)

81	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2002
12	nasIBA 12/2023 - 02/2010
11	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024 - 01/2008
10	Insulin (Novolin)FDA Link 01/2021 - 07/2008
10	Transaminases (Aminotransferases)IBA 01/2020 - 08/2003
8	EnzymesIBA 01/2023 - 08/2011
8	LipidsIBA 05/2022 - 08/2013
8	Alanine Transaminase (SGPT)IBA 01/2019 - 06/2004
8	Ribavirin (Virazole)FDA LinkGeneric 05/2015 - 07/2003
7	obeticholic acidIBA 11/2023 - 05/2016
7	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2019
7	CollagenIBA 05/2023 - 10/2018
7	Triglycerides (Triacylglycerol)IBA 12/2020 - 07/2003
6	semaglutideIBA 12/2023 - 01/2019
6	cenicrivirocIBA 10/2023 - 03/2016
6	BilirubinIBA 10/2023 - 01/2003
6	HaptoglobinsIBA 03/2022 - 01/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2003
6	Antiviral Agents (Antivirals)IBA 08/2021 - 12/2003
6	InterferonsIBA 04/2015 - 12/2003
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2022 - 01/2003
5	ThiazolidinedionesIBA 11/2014 - 02/2010
5	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 06/2010 - 01/2003
4	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2002
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2021 - 12/2013
3	tropifexorIBA 10/2023 - 01/2020
3	Complement C3 (C3 Complement)IBA 08/2023 - 09/2019
3	Protein Kinases (Protein Kinase)IBA 01/2023 - 01/2020
3	LeptinIBA 12/2022 - 10/2009
3	Syntex adjuvant formulationIBA 02/2022 - 01/2020
3	Protons (Proton)IBA 11/2021 - 03/2003
3	simtuzumabIBA 12/2019 - 05/2016
3	C-Reactive ProteinIBA 01/2019 - 10/2009
3	2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA 05/2016 - 12/2013
3	Rosiglitazone (Avandia)FDA Link 11/2014 - 07/2008
3	AdiponectinIBA 03/2012 - 07/2008
3	adefovirIBA 03/2012 - 01/2005
3	Lamivudine (Epivir)FDA Link 09/2005 - 12/2003
2	resmetiromIBA 01/2024 - 01/2024
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2023 - 01/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 01/2019
2	LDL CholesterolIBA 01/2023 - 08/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2016
2	Monoclonal AntibodiesIBA 01/2022 - 10/2018
2	TransferasesIBA 08/2021 - 06/2006
2	CC ChemokinesIBA 01/2020 - 03/2016
2	Choline (Choline Chloride)IBA 01/2020 - 12/2013
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 12/2010
2	CreatinineIBA 10/2018 - 01/2016
2	Interferon-alpha (Interferon Alfa)IBA 05/2015 - 12/2004
2	asunaprevirIBA 12/2014 - 01/2013
2	Dihydrotachysterol (AT 10)IBA 04/2014 - 10/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 04/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2013 - 12/2002
2	Transcription Factors (Transcription Factor)IBA 06/2012 - 12/2002
2	Hepatitis B e AntigensIBA 03/2012 - 07/2008

Therapy/Procedure

33	Therapeutics 12/2023 - 04/2003
7	Drug Therapy (Chemotherapy) 12/2023 - 08/2011
6	Liver Transplantation 07/2023 - 05/2015
4	Bariatric Surgery 05/2023 - 01/2017
2	Aftercare (After-Treatment) 01/2022 - 10/2013